Skip to main content
. 2017 May 1;28(4):e54. doi: 10.3802/jgo.2017.28.e54

Table 5. Comparison of OS and PFS in OMC compared to serous ovarian carcinoma.

Study Median OS (mon) Median PFS (mon)
Winter et al. [47]
Serous 45.1 16.9
Mucinous 14.8 10.5
Alexandre et al. [48]
Serous 47.2 17.5
Mucinous 21.6 11.4
Tian et al. [49]
Serous 40.5 16.7
Mucinous 11.3 9.7
Mackay et al. [50]
Serous 40.8 16.1
Mucinous 14.6 7.6

OMC, ovarian mucinous carcinoma; OS, overall survival; PFS, progression-free survival.